AVDL - Avadel Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 1.36
52-Week Change 3-12.35%
S&P500 52-Week Change 38.78%
52 Week High 35.3700
52 Week Low 31.0300
50-Day Moving Average 33.2835
200-Day Moving Average 32.2756

Share Statistics

Avg Vol (3 month) 3429.65k
Avg Vol (10 day) 3212.07k
Shares Outstanding 537.45M
Float 27.32M
% Held by Insiders 12.74%
% Held by Institutions 155.90%
Shares Short (Sep 30, 2019) 46.99M
Short Ratio (Sep 30, 2019) 48.3
Short % of Float (Sep 30, 2019) 4N/A
Short % of Shares Outstanding (Sep 30, 2019) 419.15%
Shares Short (prior month Aug 30, 2019) 46.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -135.48%
Operating Margin (ttm)-58.28%

Management Effectiveness

Return on Assets (ttm)-11.81%
Return on Equity (ttm)-333.24%

Income Statement

Revenue (ttm)74.74M
Revenue Per Share (ttm)2.01
Quarterly Revenue Growth (yoy)-39.90%
Gross Profit (ttm)85.75M
EBITDA -38.87M
Net Income Avi to Common (ttm)-101.25M
Diluted EPS (ttm)-2.7240
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)79.26M
Total Cash Per Share (mrq)2.12
Total Debt (mrq)123.35M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.89
Book Value Per Share (mrq)-0.48

Cash Flow Statement

Operating Cash Flow (ttm)-67.43M
Levered Free Cash Flow (ttm)-29.75M